AERI logo

Aerie Pharmaceuticals (AERI) Cash And Cash Equivalents

AERI Annual Cash & Cash Equivalents

$37.19 M
-$114.38 M-75.47%

31 December 2021

AERI Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AERI Quarterly Cash And Cash Equivalents

$54.09 M
+$14.65 M+37.15%

30 September 2022

AERI Quarterly Cash And Cash Equivalents Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AERI Cash And Cash Equivalents Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-75.5%-12.5%
3 y3 years-81.7%-78.3%
5 y5 years-81.2%-72.1%

AERI Cash And Cash Equivalents High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time-81.7%-80.0%

Aerie Pharmaceuticals Cash And Cash Equivalents History

DateAnnualQuarterly
Sept 2022
-
$54.09 M(+37.1%)
June 2022
-
$39.44 M(-30.1%)
Mar 2022
-
$56.44 M(+51.8%)
Dec 2021
$37.19 M(-75.5%)
$37.19 M(-39.9%)
Sept 2021
-
$61.85 M(-22.6%)
June 2021
-
$79.96 M(-34.8%)
Mar 2021
-
$122.69 M(-19.1%)
Dec 2020
$151.57 M(+5.3%)
$151.57 M(+16.8%)
Sept 2020
-
$129.79 M(-14.2%)
June 2020
-
$151.30 M(+12.8%)
Mar 2020
-
$134.18 M(-6.8%)
Dec 2019
$143.94 M(-29.0%)
$143.94 M(-42.1%)
Sept 2019
-
$248.70 M(+127.4%)
June 2019
-
$109.36 M(-26.5%)
Mar 2019
-
$148.87 M(-26.6%)
Dec 2018
$202.82 M(+2.7%)
$202.82 M(-13.7%)
Sept 2018
-
$234.95 M(-13.2%)
June 2018
-
$270.65 M(+8.5%)
Mar 2018
-
$249.50 M(+26.3%)
Dec 2017
$197.57 M
$197.57 M(+1.8%)
DateAnnualQuarterly
Sept 2017
-
$194.08 M(-20.0%)
June 2017
-
$242.65 M(+73.9%)
Mar 2017
-
$139.53 M(-29.5%)
Dec 2016
$197.94 M(+117.4%)
$197.94 M(-6.6%)
Sept 2016
-
$211.94 M(+262.2%)
June 2016
-
$58.52 M(-21.2%)
Mar 2016
-
$74.27 M(-18.4%)
Dec 2015
$91.06 M(+6.4%)
$91.06 M(-14.9%)
Sept 2015
-
$106.95 M(+6.0%)
June 2015
-
$100.92 M(-11.0%)
Mar 2015
-
$113.45 M(+32.6%)
Dec 2014
$85.59 M(+22.9%)
$85.59 M(-42.5%)
Sept 2014
-
$148.88 M(+434.1%)
June 2014
-
$27.88 M(-22.2%)
Mar 2014
-
$35.84 M(-48.5%)
Dec 2013
$69.65 M(+2281.2%)
$69.65 M(+1407.9%)
Sept 2013
-
$4.62 M(+94.3%)
June 2013
-
$2.38 M(-18.7%)
Dec 2012
$2.92 M(-80.6%)
$2.92 M
Dec 2011
$15.07 M
-

FAQ

  • What is Aerie Pharmaceuticals annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Aerie Pharmaceuticals?
  • What is Aerie Pharmaceuticals annual cash & cash equivalents year-on-year change?
  • What is Aerie Pharmaceuticals quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Aerie Pharmaceuticals?
  • What is Aerie Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

What is Aerie Pharmaceuticals annual cash & cash equivalents?

The current annual cash & cash equivalents of AERI is $37.19 M

What is the all time high annual cash & cash equivalents for Aerie Pharmaceuticals?

Aerie Pharmaceuticals all-time high annual cash & cash equivalents is $202.82 M

What is Aerie Pharmaceuticals annual cash & cash equivalents year-on-year change?

Over the past year, AERI annual cash & cash equivalents has changed by -$114.38 M (-75.47%)

What is Aerie Pharmaceuticals quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of AERI is $54.09 M

What is the all time high quarterly cash and cash equivalents for Aerie Pharmaceuticals?

Aerie Pharmaceuticals all-time high quarterly cash and cash equivalents is $270.65 M

What is Aerie Pharmaceuticals quarterly cash and cash equivalents year-on-year change?

Over the past year, AERI quarterly cash and cash equivalents has changed by -$7.75 M (-12.54%)